News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McKew John C.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
4
| McKew John C. (Chief Scientific Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 1,593 shares
@ $3.28, valued at
$5.2k
Sold 3,407 shares
@ $3.205, valued at
$10.9k
|
|
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2023 |
4
| McKew John C. (Chief Scientific Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 1,036 shares
@ $3.31, valued at
$3.4k
Sold 2,214 shares
@ $3.27, valued at
$7.2k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| McKew John C. (Chief Scientific Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 1,036 shares
@ $9.23, valued at
$9.6k
Sold 2,214 shares
@ $8.32, valued at
$18.4k
|
|
| 09/10/2021 |
4
| McKew John C. (Chief Scientific Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Sold 2,214 shares
@ $11.3, valued at
$25k
|
|
| 08/03/2021 |
4
| McKew John C. (Chief Scientific Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 04/05/2021 |
4
| McKew John C. (Chief Scientific Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Paid exercise price by delivering 1,036 shares
@ $12.25, valued at
$12.7k
|
|
| 02/03/2021 |
4
| McKew John C. (Chief Scientific Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 1,078 shares
@ $0
Granted 33,175 options to buy
@ $17.35, valued at
$575.6k
|
|
| 04/03/2020 |
4
| McKew John C. (Chief Scientific Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 13,000 shares
@ $0
Granted 65,000 options to buy
@ $7.87, valued at
$511.6k
|
|
| 03/30/2020 |
3
| McKew John C. (Chief Scientific Officer) has filed a Form 3 on LUMOS PHARMA, INC. |
|
|